Practice question

DNA vaccination concept bypasses conventional protein purification manufacturing by delivering genetic blueprint encoding protective antigen allowing host cells to synthesize immunogen in situ mimicking viral infection while noninfectious. Plasmid vector engineered with strong eukaryotic promoter typically human cytomegalovirus immediate early enhancer promoter driving high transcription, chimeric intron improving mRNA stability and export, Kozak consensus GCCACCATGG for efficient translation initiation, antigen coding sequence codon optimized for human usage bias replacing rare codons to increase expression tenfold, and bovine growth hormone polyadenylation signal specifying cleavage and poly-A adding 200 adenines. After intramuscular injection with needle or gene gun gold particles, myocytes and keratinocytes internalize negatively charged plasmid via macropinocytosis, plasmid enters nucleus through nuclear pore complex during mitosis when nuclear envelope breaks down or via active import mediated by importin. This mechanistic insight supports diagnostic and therapeutic applications while reinforcing core immunological and cell biology principles taught in advanced curricula. This mechanistic detail underpins practical applications in diagnostics, vaccine design, and biopharmaceutical manufacturing.